The company manufactures precision-moulded plastic components and sub-assemblies primarily for the automotive and consumer durable sectors, serving major clients like Whirlpool, TVS Motor, and Hyundai suppliers.
The company operates in a highly fragmented and capital-intensive plastic injection moulding industry with low barriers to entry. While long-standing relationships with OEMs suggest some switching costs, the razor-thin net margins of approximately 2.2% and low ROCE of 12.3% indicate a lack of durable pricing power or cost advantage.
Earnings are primarily reinvested into capacity expansion and new plant setups to follow customer demand. While revenue growth is strong, the incremental returns on capital are modest, and the company maintains a moderate debt-to-equity ratio to fund this growth.
The company's aggressive capacity expansion, funded by debt, collided with a cyclical downturn in the OEM sector, leaving the business with idle plants and fixed costs it could not cover on 2% margins. As interest coverage tightened, the lack of pricing power meant the company could not pass on rising raw material costs, leading to a liquidity crunch. The heavy reliance on related-party entities for core operations eventually obscured a deterioration in the balance sheet, and the market re-rated the stock as a low-quality commodity processor rather than a growth story.
RichFakir rates National Plastic Technologies Ltd's business quality as mediocre — 54/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, National Plastic Technologies Ltd is trading about 26% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on National Plastic Technologies Ltd is: Not rated. A mediocre business at a fair price — it does not make our shortlist right now.
RichFakir's educational estimate of National Plastic Technologies Ltd's fair value is about ₹287 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →